Clinical Servantsp. z o.o.
Other research and experimental development on natural sciences and engineering
Overview
Financials
Revenue history (in k)
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 80 days late).
- 2025filed
- 202409/06/2025
- 202319/06/2024
- 202203/07/2023
- 202103/10/2022
- 202028/07/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Authorized Representatives
Manner of representation
In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Jan Jakub Kruszewskiage 28 | 24 | $324.15 | 24% |
| 76 | $1,026.47 | 76% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2020-10-01.
20 2490 0005 0000 4600 4312 5684
88 2490 0005 0000 4600 5370 4153
03 2490 0005 0000 4530 1596 0699
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Dec 29, 2020 | Aid for SME access to finance — aid for start-ups | $256.3K$256,343 | Prezes Polskiej Agencji Rozwoju Przedsiębiorczości | |
| Jul 22, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,282$1,282 | Prezydent Miasta Lublin | |
| Mar 29, 2019 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $16,668$16,668 | Puławski Park Naukowo - Technologiczny sp. z o.o. |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2021-01-01 | Market launch of an innovative system for monitoring the circulation of medicinal substances in clinical trials | $258.7K$258,657 | Operational Programme Eastern Poland |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Ekamedsp. z o.o. | $1,386,944.70 | ekamed.pl | ||
| Albi-Techsp. z o.o. | $288,607.46 | albi-tech.pl | ||
| Sfpesp. z o.o. | $253,801.53 | sfpe.co.pl | ||
| OPESsp. z o.o. | $100,989.20 | opes.com.pl | ||
| Findewalsp. z o.o. | $96,002.27 | findewal.pl | ||
| L-Conesp. z o.o. | $803.90 | l-cone.pl | ||
| Heiki Heikisp. z o.o. | $113.96 | heikiheiki.com | ||
| Aeronite Technologiessp. z o.o. | $0.00 | aeronite.com | ||
| Hydrogen Betasp. z o.o. | – | hydrogen-first.com | ||
| PERRsp. z o.o. | – | invoi.eu |
FAQ
Last updated: 2026-04-11